Characterisation of Agomelatine-Induced Increase in Liver Enzymes: Frequency and Risk Factors Determined from a Pooled Analysis of 7605 Treated Patients

Agomelatine or placebo as adjunctive therapy to a mood stabiliser in bipolar I depression: Randomised double-blind placebo-controlled trial

(2016) Lakshmi N. Yatham et al.   BRITISH JOURNAL OF PSYCHIATRY

Antidepressant short-term and long-term brain effects during self-referential processing in major depression

(2016) Pauline Delaveau et al.   PSYCHIATRY RESEARCH-NEUROIMAGING

Review article: drug-induced liver injury in clinical practice

(2015) E. Björnsson   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A placebo-controlled study of three agomelatine dose regimens (10mg, 25mg, 25–50mg) in patients with major depressive disorder

(2014) Sidney H. Kennedy et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Agomelatine in Generalized Anxiety Disorder

(2014) Dan J. Stein et al.   JOURNAL OF CLINICAL PSYCHIATRY

Antidepressant efficacy of agomelatine: meta-analysis of published and unpublished studies

(2014) D. Taylor et al.   BMJ-British Medical Journal

Antidepressant-Induced Liver Injury: A Review for Clinicians

(2013) Cosmin Sebastian Voican et al.   AMERICAN JOURNAL OF PSYCHIATRY

Comparative Benefits and Harms of Second-Generation Antidepressants: Background Paper for the American College of Physicians

(2013) Gerald Gartlehner et al.   ANNALS OF INTERNAL MEDICINE

A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline

(2013) Koen Demyttenaere et al.   CNS SPECTRUMS

Agomelatina: fallo hepático fulminante en paciente con hígado graso

(2013) Fernando Gruz et al.   Gastroenterologia y Hepatologia

Efficacy of the novel antidepressant agomelatine for anxiety symptoms in major depression

(2013) Dan J Stein et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Efficacy of agomelatine and escitalopram on depression, subjective sleep and emotional experiences in patients with major depressive disorder: a 24-wk randomized, controlled, double-blind trial

(2013) Emmanuelle Corruble et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

The Efficacy of Agomelatine in Elderly Patients With Recurrent Major Depressive Disorder

(2013) Reinhard Heun et al.   JOURNAL OF CLINICAL PSYCHIATRY

Is it time to shift to better characterization of patients in trials assessing novel antidepressants? An example of two relapse prevention studies with agomelatine

(2012) Guy M. Goodwin et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Agomelatine Prevents Relapse in Generalized Anxiety Disorder

(2012) Dan J. Stein et al.   JOURNAL OF CLINICAL PSYCHIATRY

Comparison of agomelatine and escitalopram on nighttime sleep and daytime condition and efficacy in major depressive disorder patients

(2011) Maria-Antonia Quera-Salva et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Agomelatine in the Treatment of Major Depressive Disorder

(2010) Sidney H. Kennedy et al.   CNS DRUGS

Superior antidepressant efficacy results of agomelatine versus fluoxetine in severe MDD patients: a randomized, double-blind study

(2010) Anthony Hale et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Efficacy of the Novel Antidepressant Agomelatine on the Circadian Rest-Activity Cycle and Depressive and Anxiety Symptoms in Patients With Major Depressive Disorder

(2010) Siegfried Kasper et al.   JOURNAL OF CLINICAL PSYCHIATRY

Agomelatine in the Treatment of Major Depressive Disorder

(2010) Stephen M. Stahl et al.   JOURNAL OF CLINICAL PSYCHIATRY

Efficacy and Safety of Agomelatine in the Treatment of Major Depressive Disorder

(2010) John Zajecka et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Current Concepts of Mechanisms in Drug-Induced Hepatotoxicity

(2009) Stefan Russmann et al.   CURRENT MEDICINAL CHEMISTRY

Phenotypic characterization of idiosyncratic drug-induced liver injury: The influence of age and sex

(2009) M. Isabel Lucena et al.   HEPATOLOGY

Agomelatine Prevents Relapse in Patients With Major Depressive Disorder Without Evidence of a Discontinuation Syndrome

(2009) Guy M. Goodwin et al.   JOURNAL OF CLINICAL PSYCHIATRY

Epidemiology of Idiosyncratic Drug-Induced Liver Injury

(2009) Lauren Bell et al.   SEMINARS IN LIVER DISEASE

Relationship between daily dose of oral medications and idiosyncratic drug-induced liver injury: Search for signals

(2008) Craig Lammert et al.   HEPATOLOGY

Efficacy of Agomelatine in Generalized Anxiety Disorder

(2008) Dan J. Stein et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

A Double-Blind Comparison of Sexual Functioning, Antidepressant Efficacy, and Tolerability Between Agomelatine and Venlafaxine XR

(2008) Sidney H. Kennedy et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY